These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 320073)

  • 1. Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type.
    Irvine WJ; McCallum CJ; Gray RS; Campbell CJ; Duncan LJ; Farquhar JW; Vaughan H; Morris PJ
    Diabetes; 1977 Feb; 26(2):138-47. PubMed ID: 320073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet-cell antibodies and HLA type in Japanese insulin-dependent diabetics.
    Sakurami T; Nagaoka K; Nabeya N; Imura H; Kuno S
    Endocrinol Jpn; 1980 Apr; 27(2):149-52. PubMed ID: 6997023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents.
    Irvine WJ; McCallum CJ; Gray RS; Duncan LJ
    Lancet; 1977 May; 1(8020):1025-7. PubMed ID: 67485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic islet-cell antibody as a marker for asymptomatic and latent diabetes and prediabetes.
    Irvine WJ; Gray RS; McCallum CJ
    Lancet; 1976 Nov; 2(7995):1097-102. PubMed ID: 62945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet function in diabetics with persistent islet cell antibodies.
    Theophanides CG; Pyke DA; Watkins PJ
    Diabetes; 1978; 27 Suppl 1():265-6. PubMed ID: 344118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune complexes in type I diabetics with persistent islet cell antibodies.
    Irvine WJ; Di Mario U; Guy K; Borsey DQ
    J Clin Lab Immunol; 1980 Sep; 4(2):87-9. PubMed ID: 7003148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of islet cell antibodies.
    Lipton R; LaPorte RE
    Epidemiol Rev; 1989; 11():182-203. PubMed ID: 2680555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease.
    MacCuish AC; Irvine WJ; Barnes EW; Duncan LJ
    Lancet; 1974 Dec; 2(7896):1529-31. PubMed ID: 4140978
    [No Abstract]   [Full Text] [Related]  

  • 9. The prevalence of islet-cell antibodies and complement-fixing islet-cell antibodies in Japanese diabetics.
    Kobayashi T; Sawano S; Itoh T; Sugimoto T; Tanaka T; Suwa S
    Endocrinol Jpn; 1981 Aug; 28(4):429-33. PubMed ID: 6763893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-linked genes and islet-cell antibodies in diabetes mellitus.
    Lendrum R; Walker G; Cudworth AG; Woodrow JC; Gamble DR
    Br Med J; 1976 Jun; 1(6025):1565-7. PubMed ID: 776343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New findings on the pathogenesis of diabetes mellitus].
    Keller U
    Schweiz Med Wochenschr; 1986 Jan; 116(3):66-71. PubMed ID: 3511524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity in juvenile diabetics and their families.
    Bottazzo GF; Mann JI; Thorogood M; Baum JD; Doniach D
    Br Med J; 1978 Jul; 2(6131):165-8. PubMed ID: 354741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet cell antibodies and histocompatibility antigens (HLA) in insulin-dependent diabetics and their first-degree relatives.
    Barbosa J; Chavers B; Dunsworth T; Michael A
    Diabetes; 1982 Jul; 31(7):585-8. PubMed ID: 6761195
    [No Abstract]   [Full Text] [Related]  

  • 15. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and pancreatic islet cell antibodies in diabetes.
    Morris PJ; Irvine WJ; Gray RS; Duncan LJ; Vaughan H; McCallum FJ; Campbell CJ; Farquhar JW
    Lancet; 1976 Sep; 2(7987):652-3. PubMed ID: 60516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.
    Gleichmann H; Zörcher B; Greulich B; Gries FA; Henrichs HR; Betrams J; Kolb H
    Diabetologia; 1984 Jul; 27 Suppl():90-2. PubMed ID: 6383926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Islet cell antibodies in diabetic patients with other autoimmune diseases (author's transl)].
    Pujol-Borrell R; Richart C; Marti S; Gomez JM
    Nouv Presse Med; 1981 Sep; 10(34):2791-3. PubMed ID: 7031598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet-cell antibodies in diabetes mellitus.
    Lendrum R; Walker G; Cudworth AG; Theophanides C; Pyke DA; Bloom A; Gamble DR
    Lancet; 1976 Dec; 2(7998):1273-6. PubMed ID: 63747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation of islet amyloid to the clinical type of diabetes.
    Maloy AL; Longnecker DS; Greenberg ER
    Hum Pathol; 1981 Oct; 12(10):917-22. PubMed ID: 7028600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.